DOW JONES22,679.99+1627.46 7.73%
S&P 5002,663.68+175.03 7.03%
NASDAQ7,913.24+540.16 7.33%

Clearside Biomedical Q4 EPS $(0.76) Misses $(0.1) Estimate, Sales $3M Beat $2.95M Estimate

Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.1) by 660 percent. This is a 11.76 percent decrease over losses of $(0.68) per share

Benzinga · 03/11/2020 20:14

Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.1) by 660 percent. This is a 11.76 percent decrease over losses of $(0.68) per share from the same period last year. The company reported quarterly sales of $3 million which beat the analyst consensus estimate of $2.95 million by 1.69 percent. This is a 9.90K percent increase over sales of $30 thousand the same period last year.